Current Radiopharmaceuticals


Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
(Northern Ireland)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Accessed Articles

PET/CT and the Response to Immunotherapy in Lung Cancer open access plus

Volume: 13   Issue: 3
Pp: 177-184
Laura Evangelista*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449

Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications open access plus

Volume: 13   Issue: 1
Pp: 63-79
Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666190729151540

Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions open access plus

Volume: 13   Issue: 3
Pp: 218-227
Cinzia Crivellaro and Luca Guerra*
DOI: 10.2174/1874471013666200317144629

18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art open access plus

Volume: 13   Issue: 3
Pp: 228-237
Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821

Alternative and New Radiopharmaceutical Agents for Lung Cancer open access plus

Volume: 13   Issue: 3
Pp: 185-194
Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402

The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy open access plus

Volume: 13   Issue: 3
Pp: 243-248
Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210

Lung Cancer and Radiological Imaging open access plus

Volume: 13   Issue: 3
Pp: 238-242
Annalori Panunzio* and Paolo Sartori
DOI: 10.2174/1874471013666200523161849

FDG PET/CT in the Staging of Lung Cancer open access plus

Volume: 13   Issue: 3
Pp: 195-203
Mohsen Farsad*
DOI: 10.2174/1874471013666191223153755

In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells open access plus

Volume: 13   Issue: 2
Pp: 130-141
Vilde Y. Stenberg, Asta Juzeniene*, Øyvind S. Bruland and Roy H. Larsen
DOI: 10.2174/1874471013666200511000532

Radioiodination of Pimonidazole as a Novel Theranostic Hypoxia Probe

Volume: 14   Issue: 1
Pp: 46-50
Ilknur Demir Inci, Volkan Tekin, Ayfer Yurt Kilcar, Ozge Kozgus Guldu, Emin Ilker Medine, Kadriye Busra Karatay, Emine Dervis and Fazilet Zumrut Biber Muftuler*
DOI: 10.2174/1874471013666200331114908

Radiotherapy Planning and Molecular Imaging in Lung Cancer open access plus

Volume: 13   Issue: 3
Pp: 204-217
Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154

99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases) open access plus

Volume: 13   Issue: 3
Pp: 166-176
Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610

Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue open access plus

Volume: 13   Issue: 2
Pp: 107-119
Victoria Trindade* and Henia Balter
DOI: 10.2174/1874471012666190916112904

Animal Models for the Evaluation of Theranostic Radiopharmaceuticals

Volume: 14   Issue: 1
Pp: 15-22
Selin Soyluoglu* and Gulay Durmus-Altun
DOI: 10.2174/1874471013666200425223428

Physiological Animal Imaging with 68Ga-Citrate

Volume: 14   Issue: 1
Pp: 51-56
Ayşe Uğur and Aziz Gültekin*
DOI: 10.2174/1874471013666200421114031